Shipwaves Online to Raise Rs 14.99 Crore via Preferential Warrant Issue

OTHER
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Shipwaves Online to Raise Rs 14.99 Crore via Preferential Warrant Issue

Shipwaves Online Limited has announced a Rs 14.99 crore capital infusion through the issuance of 3.33 crore fully convertible warrants. The issue, priced at Rs 4.50 per warrant, sees significant participation from promoter group Mukka Proteins Limited. The funds will be raised in stages, with 25% paid upfront and the remainder upon conversion within 18 months, subject to shareholder approval at the upcoming AGM.

Shipwaves Online Announces Rs 14.99 Crore Preferential Issue

Total Fundraise: Rs 14.99 Crore | Warrant Issue Price: Rs 4.50 per unit

Reader Takeaway: Promoter-backed capital infusion supports liquidity but introduces potential equity dilution for existing shareholders upon future warrant conversion.

What just happened

Shipwaves Online Limited's Board of Directors has approved the issuance of 3,33,20,000 fully convertible warrants on a preferential basis. Each warrant carries an issue price of Rs 4.50, aggregating to a total value of Rs 14.99 crore. The structure allows for conversion into equity shares at a face value of Re 1 with a premium of Rs 3.50. Investors are required to pay 25% of the total amount upfront, with the remaining 75% due at the time of exercise within an 18-month window.

Why this matters

The capital raise signifies a strategic liquidity boost for the company. Notably, the bulk of the subscription is allocated to the promoter group, Mukka Proteins Limited, which has subscribed to 2,93,20,000 warrants. This demonstrates continued promoter commitment to the firm's growth plans.

Governance and Approval

The proposal must now clear the shareholder voting process via a special resolution. The company has scheduled its 11th Annual General Meeting for September 30, 2026, to be conducted via video conferencing. Mr. Chethan Nayak K has been appointed as the scrutinizer to oversee the e-voting procedures.

Risks to watch

Investors should consider the dilution effect once these warrants are converted into equity shares. While the infusion is positive for the balance sheet, the increase in share count will adjust the earnings per share (EPS) metrics in the future. The conversion is dependent on market conditions and the strategic decisions of the warrant holders over the next 18 months.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.